Kazia Therapeutics-Spon ADRKZIA
13F holders, Q1 2024 (March 31)11holders
$0.31avg. 13F price*
At the end of Q1 2024, 11 institutions reported holding Kazia Therapeutics-Spon ADR (KZIA) in their 13F filings. The largest holders were Morgan Stanley ($61K), HSBC Holdings PLC ($20K) and BNP Paribas Financial Markets ($15K).
- Company
- Kazia Therapeutics-Spon ADR
- CUSIP
- 48669G105
- Latest filing quarter
- Q3 2024
History
Number of 13F holders
Total Exit/New Position Q1 2024
| Institutions | Total Value | |
|---|---|---|
| New Positions | 3 | $4K |
| Exits | 10 | $2.0M |
Ownership 11 holders
| Morgan Stanley | 0.00% | Reduce -1.8% | 197,850 | $61K |
| HSBC Holdings PLC | 0.00% | Reduce -36.2% | 63,956 | $20K |
| BNP Paribas Financial Markets | 0.00% | Add +282.7% | 48,600 | $15K |
| XTX Topco Ltd | 0.00% | Reduce -4.9% | 18,487 | $6K |
| Two Sigma Securities, LLC | 0.00% | Reduce -68.5% | 18,424 | $6K |
| Rhumbline Advisers | 0.00% | Add +25.3% | 12,170 | $4K |
| Ground Swell Capital, LLC | 0.00% | New | 11,150 | $4K |
| Wells Fargo & Company | 0.00% | New | 500 | $155 |
| Allworth Financial LP | 0.00% | No change | 87 | $27 |
| AdvisorNet Financial, Inc | 0.00% | No change | 5 | $2 |
| JPMorgan Chase & Co. | 0.00% | New | 3 | $1 |
"% of holder's portfolio" is KZIA's weight in each manager's 13F, not the share of Kazia Therapeutics-Spon ADR the manager owns.